01438oam 2200457 450 991071717110332120220218090143.0(CKB)5470000002528503(OCoLC)1274026019(OCoLC)995470000002528503(EXLCZ)99547000000252850320210621d2021 ua 0engur|||||||||||txtrdacontentcrdacontentcrrdacarrierBiomedical research information on federal contributions to remdesivir: report to congressional committees /Candice N. WrightWashington, DC :United States Government Accountability Office,2021.1 online resource (ii, 35 pages) illustrations"March 2021.""GAO-21-272."Includes bibliographical references.Biomedical research Antiviral agentsUnited StatesCOVID-19 (Disease)TreatmentCOVID-19 (Disease)TreatmentfastAntiviral agentsCOVID-19 (Disease)Treatment.COVID-19 (Disease)Treatment.Wright Candice N.S2HS2HOCLCFGPOOCLCOGPOBOOK9910717171103321Biomedical research799310UNINA